Liquidia (Morrisville, NC) a development-stage company focused on improving delivery of inhaled therapeutics and vaccines via nanoparticles with optimized characteristics for increased target specificity, closed a $7M Series C financing. Participants include Canaan Partners, Pappas Ventures, New Enterprise Associates and Firelake Capital.